SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWarpaint London Regulatory News (W7L)

Share Price Information for Warpaint London (W7L)

Share Price is delayed by 15 minutes
Get Live Data
212.50    -2.50 (-1.16%)
Bid:
210.00
Ask:
215.00
Spread: 5.00 (2.381%)
Market Cap: £171.67m
W7L Live PriceLast checked at - London Stock Exchange

Intraday Warpaint London Share Chart

BLOCK LISTING RETURN

9 Apr 2025 15:07

RNS Number : 3692E
Warpaint London PLC
09 April 2025
 

9 April 2025

 

 

Warpaint London PLC

("Warpaint", the "Company" or the "Group")

 

BLOCK LISTING RETURN

 

 

Warpaint London plc (AIM: W7L; OTCQX: WPNTF), the specialist supplier of colour cosmetics and owner of the W7, Technic, Skin and Tan, Super Facialist, Dirty Works and Fish Soho brands, gives the below information required by Schedule 6 of the AIM Rules for Companies in connection with the Warpaint London plc Company Share Option Plan (2021) and the Company's Enterprise Management Incentive Scheme.

 

 

Name of applicant:

Warpaint London PLC

Name of scheme:

Warpaint London plc Company Share Option Plan (2021) and the Company's Enterprise Management Incentive Scheme

Period of return:

From:

9 October 2024

To:

9 April 2025

Balance under scheme from previous return:

10,842 Ordinary Shares of 25p each in the Company ("Ordinary Shares")

The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return:

Nil Ordinary Shares

Number of securities issued/allotted under scheme during period:

Nil Ordinary Shares

 

Balance under scheme not yet issued/allotted at end of period

10,842 Ordinary Shares

Number and class of securities originally listed and the date of admission

625,577 Ordinary Shares on 9 October 2023

Total number of securities in issue at the end of the period

 80,787,321 Ordinary Shares

Name of contact:

Neil Rodol

Telephone number of contact:

As below

 

 

In compliance with the FCA's Disclosure Guidance and Transparency Rules (the "Rules"), the Company announces that, as at the date of this announcement, it has 80,787,321 Ordinary Shares in issue. The Company does not hold any Ordinary Shares in treasury and all of the Ordinary Shares have equal voting rights.

 

 

The figure of 80,787,321 Ordinary Shares represents the total voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Rules.

 

Enquiries:

 

Warpaint London

Sam Bazini - Chief Executive Officer

Eoin Macleod - Managing Director

Neil Rodol - Chief Financial Officer

c/o IFC

 

 

Shore Capital (Nominated Adviser & Broker)

Patrick Castle, Daniel Bush - Corporate Advisory

Fiona Conroy - Corporate Broking

 

020 7408 4090

IFC Advisory (Financial PR & IR)

Tim Metcalfe, Graham Herring, Florence Staton

020 3934 6630

 

 

Warpaint London plc

 

Warpaint sells branded cosmetics under the lead brand names of W7 and Technic. W7 is sold in the UK primarily to major retailers and internationally to local distributors or retail chains. The Technic brand is sold in the UK and continental Europe with a significant focus on the gifting market, principally for high street retailers and supermarkets. In addition, Warpaint supplies cosmetics under its other brand names of Man'stuff, Body Collection and Chit Chat, each targeting a different demographic. Additionally, in February 2025, Warpaint acquired a number of leading health, beauty and personal care brands that complement its existing cosmetics brands, including Skin & Tan, Super Facialist, Dirty Works and Fish Soho.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BLREALLNEEKSEFA
Date   Source Headline
19th Feb 20217:00 amRNSWard & Hagon Contract Renewal
10th Feb 20212:56 pmRNSHolding(s) in Company
22nd Jan 20214:00 pmRNSTransfer of Shares and Director/PDMR Shareholding
18th Jan 20217:00 amRNSFull Year Trading Update
10th Dec 20203:03 pmRNSHolding(s) in Company
17th Nov 20207:00 amRNSUK Retail Update
23rd Sep 20207:00 amRNSInterim Results
4th Sep 20207:00 amRNSNotice of Results
16th Jul 20207:00 amRNSChange of Advisers
26th Jun 202012:24 pmRNSResult of AGM
26th Jun 20207:00 amRNSAGM Statement
15th Jun 20207:00 amRNSEquity Development Investor Webinar
1st Jun 20204:36 pmRNSPrice Monitoring Extension
1st Jun 20202:00 pmRNSNotice of AGM and Posting of Annual Report
1st Jun 20207:00 amRNSFurther UK Retail Expansion
21st May 20207:00 amRNSShare Option Plan, Grant of Options & PDMR Holding
13th May 20207:00 amRNSFinal Results for the year ended 31 December 2019
11th May 20204:29 pmRNSHolding(s) in Company
29th Apr 20204:35 pmRNSHolding(s) in Company
9th Apr 20207:00 amRNSCovid-19 Update and Notice of Results
19th Mar 20207:00 amRNSUpdate regarding Covid-19
18th Mar 20204:42 pmRNSSecond Price Monitoring Extn
18th Mar 20204:38 pmRNSPrice Monitoring Extension
18th Mar 20202:06 pmRNSSecond Price Monitoring Extn
18th Mar 20202:01 pmRNSPrice Monitoring Extension
6th Feb 20207:00 amRNSUK Retail Expansion & Trading Update
20th Dec 20197:00 amRNSTrading Update
16th Oct 20194:28 pmRNSDirector Dealings
24th Sep 20197:08 amRNSHolding(s) in Company
20th Sep 20192:25 pmRNSHolding(s) in Company
18th Sep 20197:00 amRNSInterim Results for the six months to 30 June 2019
19th Aug 20197:00 amRNSAppointment of Joint Broker
6th Aug 20197:00 amRNSTrading Update and Notice of Results
11th Jun 20197:00 amRNSChange of Adviser
21st May 20191:54 pmRNSHolding(s) in Company
21st May 201911:55 amRNSResult of AGM
21st May 201910:59 amRNSAGM Statement
26th Apr 20192:10 pmRNSPosting of Annual Report and Notice of AGM
24th Apr 20193:13 pmEQSHardman & Co Research: Warpaint London Plc (W7L): FY'18 sales: remains profitable despite weak UK market
10th Apr 20197:00 amRNSResults for the 12 months ended 31 December 2018
3rd Apr 20197:00 amRNSNotice of Results
11th Mar 20193:19 pmRNSHolding(s) in Company
22nd Feb 20194:21 pmRNSHolding(s) in Company
20th Feb 201912:58 pmRNSHolding(s) in Company
29th Jan 20197:00 amRNSTrading Update
1st Nov 201812:45 pmEQSHardman & Co Research: Warpaint London Plc (W7L): Trading update: softening UK market
31st Oct 20187:00 amRNSHolding(s) in Company
30th Oct 201811:52 amRNSDirector Dealings
29th Oct 20189:05 amRNSSecond Price Monitoring Extn
29th Oct 20189:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.